RecruitingPhase 2NCT07124078
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Incyte Corporation
- Principal Investigator
- Incyte Medical MonitorIncyte Corporation
- Intervention
- INCA034176(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2026 – 2029
Study locations (30)
- City of Hope Medical Center, Duarte, California, United States
- Lucile Packard Child Hospital End, Stanford, California, United States
- Childrens National Medical Center, Washington D.C., District of Columbia, United States
- Adventhealth Pediatric Cellular Therapy and Blood and Marrow Transplant, Orlando, Florida, United States
- Childrens Healthcare of Atlanta, Atlanta, Georgia, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Levine Cancer Institute, Charlotte, North Carolina, United States
- Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- Hôpital Universitaire Des Enfants Reine Fabiola, Brussels, Belgium
- Universite Catholique de Louvain (Ucl) - Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Belgium
- Charite Campus Virchow, Berlin, Germany
- Klinikum Der Johann Wolfgang Goethe-Universitaet, Frankfurt am Main, Germany
- Universitaetsklinikum Freiburg Zentrum Fuer Kinderheilkunde- Und Jugendmedizin Klinik Iv: Paediatris, Freiburg im Breisgau, Germany
- Universitaetsklinikum Hamburg-Eppendorf, Hamburg, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07124078 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo
- RECRUITINGPHASE2NCT07116031A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)Sanofi